Validation of the Kidney Failure Risk Equation in Manitoba-Reference-Cited by-同舟云学术

Validation of the Kidney Failure Risk Equation in Manitoba

Published:2017-01 Issue: Volume:4 Page:205435811770537
ISSN:2054-3581
Container-title:Canadian Journal of Kidney Health and Disease
language:en
Short-container-title:Can J Kidney Health Dis

Author:

Whitlock Reid H.¹²,Chartier Mariette¹³,Komenda Paul¹²⁴,Hingwala Jay⁴⁵,Rigatto Claudio¹²⁴,Walld Randy³,Dart Allison¹,Tangri Navdeep¹²⁴

Affiliation:

1. Department of Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada

2. Chronic Disease Innovation Centre, Seven Oaks General Hospital, Winnipeg, Manitoba, Canada

3. Manitoba Centre for Health Policy, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada

4. Section of Nephrology, Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada

5. Health Sciences Centre, Winnipeg, Manitoba, Canada

Funder

Manitoba Medical Services Foundation

Publisher

SAGE Publications

Subject

Nephrology

Link

http://journals.sagepub.com/doi/pdf/10.1177/2054358117705372

Reference37 articles.

1. Classification of Chronic Kidney Disease: A Step Forward

2. Chronic kidney disease: global dimension and perspectives

3. Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey

4. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

5. Impact of timing of nephrology referral and pre-ESRD care on mortality risk among new ESRD patients in the United States

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A note on performance metrics for the Kidney Failure Risk Equation;Nephrology Dialysis Transplantation;2024-04-27

2. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease;Kidney International;2024-04

3. Utilization of the corticomedullary difference in magnetic resonance imaging-derived apparent diffusion coefficient for noninvasive assessment of chronic kidney disease in type 2 diabetes;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2024-02

4. Early prediction of end-stage kidney disease using electronic health record data: a machine learning approach with a 2-year horizon;JAMIA Open;2024-01-04

5. Clinical Decision Support Tools in the Electronic Medical Record;Kidney International Reports;2024-01